<DOC>
	<DOCNO>NCT00050908</DOCNO>
	<brief_summary>This substudy ACTG A5142 . The purpose substudy evaluate blood vessel function HIV-infected patient take anti-HIV drug .</brief_summary>
	<brief_title>Blood Vessel Function HIV-Infected Patients Taking Anti-HIV Drugs</brief_title>
	<detailed_description>Endothelial dysfunction , assess measurement brachial artery reactivity , associate coronary artery disease . Previous study show patient take HIV protease inhibitor ( PIs ) buildup fatty deposit artery impair flow-mediated vasodilation brachial artery , whereas endothelial function normal HIV-infected individual take PIs . The effect three different antiretroviral regimen endothelial function antiretroviral na√Øve HIV-infected patient examine substudy . Patients substudy Brachial Artery Reactivity Tests ( BARTs ) , painless ultrasound test artery low arm . Brachial artery reactivity measure entry 4 24 week patient randomize one three open-label drug regimen ACTG A5142 . Brachial artery reactivity response two vasoactive stimulus ( flow-mediated nitroglycerin ) assess measure brachial artery diameter flow velocity . Blood drawn Weeks 4 24 insulin lipid test . Patients fast refrain tobacco caffeine use least 8 hour prior study visit . For duration substudy , patient ask change amount fruit , juice , antioxidant , tea consume .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Participation ACTG A5142 . Able willing give write informed consent report current smoking status . Men stable testosterone replacement least 3 month prior entry plan continue receive stable dose substudy may enroll . Men discontinue testosterone therapy must least 3 month eligible . Women receive oral contraceptive , hormone replacement , progestational derivative must stable regimen least 3 month prior enrollment must plan remain dose duration study . Women discontinue therapy must least 3 month eligible . Coronary heart disease , peripheral vascular disease , cerebrovascular disease . Diabetes mellitus , exception previous history gestational steroidinduced diabetes mellitus within 12 week prior substudy entry . Insulinsensitizing agent metformin , pioglitazone , rosiglitazone . Lipidlowering drug within 6 week prior substudy entry . Systemic glucocorticoid , longacting inhaled steroid , certain anabolic steroid within 30 day prior substudy entry . Uncontrolled hypertension . Heavy use vitamin supplement .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Brachial Artery</keyword>
	<keyword>Endothelium , Vascular</keyword>
	<keyword>Vasodilation</keyword>
	<keyword>Nitroglycerin</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>efavirenz</keyword>
	<keyword>lopinavir</keyword>
	<keyword>stavudine</keyword>
	<keyword>lamivudine</keyword>
	<keyword>zidovudine</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>